APA

Ji S. H., Park Y. S., Lee J., Lim D. H., Park B., Park K. W., Kang J. H., Lee S., Park J. O., Kim K., Kim W. S., Jung C. W., Im Y., Kang W. K. & Park K. (20050616). Phase II study of irinotecan, 5-fluorouracil and leucovorin as first-line therapy for advanced colorectal cancer. : Japanese journal of clinical oncology.

Chicago

Ji Sang Hoon, Park Young Suk, Lee Jeeyun, Lim Do Hyoung, Park Byeong-Bae, Park Keun Woo, Kang Jung Hun, Lee Se-Hoon, Park Joon Oh, Kim Kihyun, Kim Won Seog, Jung Chul Won, Im Young-Hyuck, Kang Won Ki and Park Keunchil. 20050616. Phase II study of irinotecan, 5-fluorouracil and leucovorin as first-line therapy for advanced colorectal cancer. : Japanese journal of clinical oncology.

Harvard

Ji S. H., Park Y. S., Lee J., Lim D. H., Park B., Park K. W., Kang J. H., Lee S., Park J. O., Kim K., Kim W. S., Jung C. W., Im Y., Kang W. K. and Park K. (20050616). Phase II study of irinotecan, 5-fluorouracil and leucovorin as first-line therapy for advanced colorectal cancer. : Japanese journal of clinical oncology.

MLA

Ji Sang Hoon, Park Young Suk, Lee Jeeyun, Lim Do Hyoung, Park Byeong-Bae, Park Keun Woo, Kang Jung Hun, Lee Se-Hoon, Park Joon Oh, Kim Kihyun, Kim Won Seog, Jung Chul Won, Im Young-Hyuck, Kang Won Ki and Park Keunchil. Phase II study of irinotecan, 5-fluorouracil and leucovorin as first-line therapy for advanced colorectal cancer. : Japanese journal of clinical oncology. 20050616.